The evidence from several sources including users is that the Evolis products work. The market potential is huge and traction is underway. CDY could turn a profit in FY 2017-18 on Evolis alone. Importantly also is the prospect the Midkine story will unfold as game changer. CDY's present market cap of ~$2m may become the most obvious >10o banger since CSL listed.
The evidence from several sources including users is that the...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable